An autoregulatory loop between Nrf2 and Cul3-Rbx1 controls their cellular abundance.
The INrf2 (Keap1)/Cul3-Rbx1 complex constantly degrades Nrf2 under normal conditions. When a cell encounters oxidative or electrophilic stress, Nrf2 dissociates from the INrf2/Cul3-Rbx1 complex and translocates into the nucleus. In the nucleus, Nrf2 activates a myriad of antioxidant and defensive genes that protect cells. Nrf2 is then exported out of the nucleus and degraded. INrf2 serves as a substrate adaptor to link Nrf2 to Cul3 and Rbx1. Cul3 and Rbx1 make up the ubiquitin ligase complex that is responsible for the ubiquitination and degradation of Nrf2. Previously we have shown a feedback autoregulatory loop between Nrf2 and INrf2 indicating that Nrf2 regulates INrf2 by controlling its transcription. Here we are extending this research by demonstrating the presence of another feedback autoregulatory loop between Cul3-Rbx1 and Nrf2. Experiments using Hepa-1 and HepG2 cells indicate that Nrf2 controls its own degradation by regulating expression and induction of Cul3-Rbx1 genes. Treatment with the antioxidant tert-Butylhydroquinone (t-BHQ) leads to induction of Cul3-Rbx1 genes. Mutagenesis and transfection experiments identified an antioxidant response element in the forward and reverse strands of the proximal Cul3 and Rbx1 promoters, respectively, that Nrf2 binds and regulates expression and antioxidant induction of the Cul3-Rbx1 genes. In addition, short interfering RNA inhibition and overexpression of Nrf2 led to a respective decrease and increase in Cul3-Rbx1 gene expression. The increase in Cul3-Rbx1 leads to ubiquitination and degradation of Nrf2. These data suggest that Nrf2 regulates Cul3-Rbx1 by controlling regulation of expression and induction of Cul3-Rbx1. The induction of Cul3-Rbx1 control Nrf2 by increasing degradation.
Kaspar
James W
JW
Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.
Jaiswal
Anil K
AK
D000818:Animals; D000975:Antioxidants / Q000378:metabolism; D002352:Carrier Proteins / Q000378:metabolism*; D045744:Cell Line, Tumor; D044842:Cullin Proteins / Q000378:metabolism*; D005786:Gene Expression Regulation; D006801:Humans; D051379:Mice; D008954:Models, Biological; D051267:NF-E2-Related Factor 2 / Q000378:metabolism*; D014158:Transcription, Genetic; D025801:Ubiquitin / Q000378:metabolism
D000975:Antioxidants; C503645:CUL3 protein, human; D002352:Carrier Proteins; C503646:Cul3 protein, mouse; D044842:Cullin Proteins; D051267:NF-E2-Related Factor 2; C495635:NFE2L2 protein, human; C495636:Nfe2l2 protein, mouse; C479529:RBX1 protein, human; C540494:RBX1 protein, mouse; D025801:Ubiquitin
J Biol Chem. 2007 Jun 1;282(22):16502-10
17403689
J Biol Chem. 2009 May 15;284(20):13856-13868
19279002
J Biol Chem. 2003 Nov 7;278(45):44675-82
12947090
Oncogene. 2001 Jun 28;20(29):3906-17
11439354
Hepatology. 2007 Nov;46(5):1597-610
17668877
Free Radic Biol Med. 1995 Jun;18(6):1033-77
7628729
Genes Cells. 2003 Apr;8(4):379-91
12653965
Mol Cell Biol. 2005 Jan;25(1):162-71
15601839
Genes Dev. 1999 Jan 1;13(1):76-86
9887101
Mol Cell Biol. 2005 Jun;25(12):4914-23
15923610
Free Radic Biol Med. 2004 May 15;36(10):1199-207
15110384
Annu Rev Microbiol. 1999;53:495-523
10547699
Mech Dev. 1991 Mar;34(1):3-9
1911393
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3410-5
11248092
J Biol Chem. 2005 Aug 12;280(32):29158-68
15901726
Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2046-51
14764898
Physiol Rev. 1993 Oct;73(4):797-821
8415926
Mol Cell Biol. 2004 Dec;24(24):10941-53
15572695
J Biol Chem. 2003 Jan 24;278(4):2396-402
12441344
Nat Genet. 2003 Nov;35(3):238-45
14517554
Biochem J. 2004 Jun 1;380(Pt 2):515-21
14960151
J Biol Chem. 2006 Apr 28;281(17):12132-42
16513647
Drug Metab Rev. 2006;38(4):769-89
17145701
Curr Top Cell Regul. 2000;36:201-16
10842753
Oncogene. 2002 Oct 3;21(44):6829-34
12360409
Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14960-5
8962164
Free Radic Biol Med. 2006 Apr 1;40(7):1119-30
16545679
J Biol Chem. 1990 Aug 25;265(24):14648-53
2387873
J Clin Oncol. 2005 Jul 20;23(21):4776-89
16034054
Adv Enzyme Regul. 2006;46:113-40
16887173
Toxicology. 2008 Apr 3;246(1):24-33
18083283
J Biol Chem. 2003 Feb 14;278(7):4536-41
12446695
Mol Cell. 2003 Sep;12(3):783-90
14527422
Cancer Res. 2007 Jan 15;67(2):546-54
17234762